Annual Net Income
-$98.79 M
+$58.25 M+37.09%
31 December 2023
Summary:
Relmada Therapeutics annual net profit is currently -$98.79 million, with the most recent change of +$58.25 million (+37.09%) on 31 December 2023. During the last 3 years, it has fallen by -$39.34 million (-66.16%). RLMD annual net income is now -816360.33% below its all-time high of -$12.10 thousand, reached on 31 August 2012.RLMD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$21.73 M
-$3.96 M-22.28%
30 September 2024
Summary:
Relmada Therapeutics quarterly net profit is currently -$21.73 million, with the most recent change of -$3.96 million (-22.28%) on 30 September 2024. Over the past year, it has increased by +$276.10 thousand (+1.25%). RLMD quarterly net income is now -459.56% below its all-time high of $6.04 million, reached on 30 June 2015.RLMD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$86.49 M
+$276.10 K+0.32%
30 September 2024
Summary:
Relmada Therapeutics TTM net profit is currently -$86.49 million, with the most recent change of +$276.10 thousand (+0.32%) on 30 September 2024. Over the past year, it has increased by +$25.08 million (+22.48%). RLMD TTM net income is now -731.39% below its all-time high of $13.70 million, reached on 30 September 2015.RLMD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.1% | +1.3% | +22.5% |
| 3 y3 years | -66.2% | +49.0% | +22.9% |
| 5 y5 years | -470.4% | -492.1% | -391.2% |
RLMD Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.2% | +37.1% | -22.3% | +49.0% | at high | +44.9% |
| 5 y | 5 years | -1105.3% | +37.1% | -492.1% | +49.0% | -391.2% | +44.9% |
| alltime | all time | <-9999.0% | +37.1% | -459.6% | +49.0% | -731.4% | +44.9% |
Relmada Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.73 M(+22.3%) | -$86.49 M(-0.3%) |
| June 2024 | - | -$17.77 M(-18.6%) | -$86.76 M(-8.0%) |
| Mar 2024 | - | -$21.83 M(-13.3%) | -$94.30 M(-4.5%) |
| Dec 2023 | -$98.79 M(-37.1%) | -$25.17 M(+14.4%) | -$98.79 M(-11.5%) |
| Sept 2023 | - | -$22.00 M(-13.0%) | -$111.57 M(-13.5%) |
| June 2023 | - | -$25.30 M(-3.9%) | -$128.99 M(-10.2%) |
| Mar 2023 | - | -$26.32 M(-30.6%) | -$143.62 M(-8.5%) |
| Dec 2022 | -$157.04 M(+24.9%) | -$37.94 M(-3.7%) | -$157.04 M(+2.3%) |
| Sept 2022 | - | -$39.42 M(-1.3%) | -$153.48 M(-2.0%) |
| June 2022 | - | -$39.94 M(+0.5%) | -$156.67 M(+9.3%) |
| Mar 2022 | - | -$39.75 M(+15.6%) | -$143.28 M(+13.9%) |
| Dec 2021 | -$125.75 M(+111.5%) | -$34.38 M(-19.3%) | -$125.75 M(+12.1%) |
| Sept 2021 | - | -$42.61 M(+60.5%) | -$112.14 M(+29.7%) |
| June 2021 | - | -$26.55 M(+19.5%) | -$86.43 M(+21.7%) |
| Mar 2021 | - | -$22.22 M(+7.0%) | -$71.00 M(+19.4%) |
| Dec 2020 | -$59.46 M(+625.4%) | -$20.76 M(+22.8%) | -$59.46 M(+53.7%) |
| Sept 2020 | - | -$16.90 M(+52.0%) | -$38.69 M(+52.0%) |
| June 2020 | - | -$11.12 M(+4.2%) | -$25.46 M(+37.9%) |
| Mar 2020 | - | -$10.67 M(+190.9%) | -$18.47 M(+4.9%) |
| Dec 2019 | -$8.20 M(-52.7%) | - | - |
| Sept 2019 | - | -$3.67 M(-11.0%) | -$17.61 M(+1.7%) |
| June 2019 | -$17.32 M(+93.3%) | -$4.12 M(+53.5%) | -$17.32 M(+4.7%) |
| Mar 2019 | - | -$2.69 M(-62.3%) | -$16.55 M(-3.0%) |
| Dec 2018 | - | -$7.13 M(+110.9%) | -$17.06 M(+50.2%) |
| Sept 2018 | - | -$3.38 M(+0.9%) | -$11.36 M(+26.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | -$8.96 M(+42.5%) | -$3.35 M(+4.6%) | -$8.96 M(+23.7%) |
| Mar 2018 | - | -$3.20 M(+124.3%) | -$7.24 M(+20.3%) |
| Dec 2017 | - | -$1.43 M(+45.4%) | -$6.02 M(+7.0%) |
| Sept 2017 | - | -$981.70 K(-39.9%) | -$5.63 M(-10.5%) |
| June 2017 | -$6.29 M(+111.3%) | -$1.63 M(-17.6%) | -$6.29 M(-21.1%) |
| Mar 2017 | - | -$1.98 M(+92.2%) | -$7.97 M(+1.6%) |
| Dec 2016 | - | -$1.03 M(-37.2%) | -$7.85 M(-15.4%) |
| Sept 2016 | - | -$1.64 M(-50.5%) | -$9.28 M(+211.9%) |
| June 2016 | -$2.97 M(-85.7%) | -$3.32 M(+78.4%) | -$2.97 M(-146.6%) |
| Mar 2016 | - | -$1.86 M(-24.4%) | $6.38 M(+10.4%) |
| Dec 2015 | - | -$2.46 M(-152.8%) | $5.78 M(-57.8%) |
| Sept 2015 | - | $4.66 M(-22.8%) | $13.70 M(-165.8%) |
| June 2015 | -$20.80 M(-2.5%) | $6.04 M(-345.3%) | -$20.80 M(-22.5%) |
| Mar 2015 | - | -$2.46 M(-145.1%) | -$26.85 M(+10.1%) |
| Dec 2014 | - | $5.46 M(-118.3%) | -$24.39 M(-18.3%) |
| Sept 2014 | - | -$29.84 M(>+9900.0%) | -$29.86 M(>+9900.0%) |
| June 2014 | -$21.34 M(>+9900.0%) | - | - |
| Feb 2014 | - | -$3100.00(-78.5%) | -$49.40 K(-2.0%) |
| Nov 2013 | - | -$14.40 K(+16.1%) | -$50.40 K(+12.0%) |
| Aug 2013 | -$45.00 K(+271.9%) | -$12.40 K(-36.4%) | -$45.00 K(+9.2%) |
| May 2013 | - | -$19.50 K(+375.6%) | -$41.20 K(+70.2%) |
| Feb 2013 | - | -$4100.00(-54.4%) | -$24.20 K(+17.5%) |
| Nov 2012 | - | -$9000.00(+4.7%) | -$20.60 K(+77.6%) |
| Aug 2012 | -$12.10 K | -$8600.00(+244.0%) | -$11.60 K(+286.7%) |
| May 2012 | - | -$2500.00(+400.0%) | -$3000.00(+500.0%) |
| Feb 2012 | - | -$500.00 | -$500.00 |
FAQ
- What is Relmada Therapeutics annual net profit?
- What is the all time high annual net income for Relmada Therapeutics?
- What is Relmada Therapeutics annual net income year-on-year change?
- What is Relmada Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly net income year-on-year change?
- What is Relmada Therapeutics TTM net profit?
- What is the all time high TTM net income for Relmada Therapeutics?
- What is Relmada Therapeutics TTM net income year-on-year change?
What is Relmada Therapeutics annual net profit?
The current annual net income of RLMD is -$98.79 M
What is the all time high annual net income for Relmada Therapeutics?
Relmada Therapeutics all-time high annual net profit is -$12.10 K
What is Relmada Therapeutics annual net income year-on-year change?
Over the past year, RLMD annual net profit has changed by +$58.25 M (+37.09%)
What is Relmada Therapeutics quarterly net profit?
The current quarterly net income of RLMD is -$21.73 M
What is the all time high quarterly net income for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly net profit is $6.04 M
What is Relmada Therapeutics quarterly net income year-on-year change?
Over the past year, RLMD quarterly net profit has changed by +$276.10 K (+1.25%)
What is Relmada Therapeutics TTM net profit?
The current TTM net income of RLMD is -$86.49 M
What is the all time high TTM net income for Relmada Therapeutics?
Relmada Therapeutics all-time high TTM net profit is $13.70 M
What is Relmada Therapeutics TTM net income year-on-year change?
Over the past year, RLMD TTM net profit has changed by +$25.08 M (+22.48%)